Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD

Inclusion Criteria: * Healthy female and male subjects between 18 to 75 years of age with Fitzpatrick Skin Type I - VI. * Able and willing to comply with the treatment/follow-up schedule and requirements comply with all study (protocol) requirements. * Willingness to provide signed, informed consent to participate in the study * Willing to have photographs and images taken of the treated areas to be used in evaluations, publications, presentations, and marketing materials * Has Tear Breakup Time (TBUT) ≤ 7 seconds at screening/baseline * Has Meibomian gland secretion score (MGS) ≤ 12 at screening/ baseline * Has at least 5 non-atrophied meibomian glands and at least 50% of working meibomian glands in the lower eyelid at screening/ baseline * Symptoms self-assessed using the OSDI questionnaire ≥ 23 at screening/ baseline Exclusion Criteria: * Contact lens wear within the month prior to screening * Unwilling to discontinue use of contact lenses for the duration of the study * Ocular surgery or eyelid surgery, within 6 months prior to screening * Neuro-paralysis in the planned treatment area, within 6 months prior to screening * Other uncontrolled eye disorders affecting the ocular surface, for example active allergies * Current use of punctal plugs * Pre-cancerous lesions, skin cancer or pigmented lesions in the planned treatment area * Uncontrolled infections or uncontrolled immunosuppressive diseases * Subjects with ocular infections, within 6 months prior to screening * P…